Exogenous administration of glucocorticoids is a widely used and efficient tool to investigate the effects of elevated concentrations of these hormones in field studies. Because the effects of corticosterone are dose and duration-dependent, the exact course of plasma corticosterone levels after exogenous administration needs to be known. We tested the performance of self-degradable corticosterone pellets (implanted under the skin) in elevating plasma corticosterone levels. We monitored baseline (sampled within 3 min after capture) total corticosterone levels and investigated potential interactions with corticosteroid-binding-globulin (CBG) capacity and the endogenous corticosterone response to handling in Eurasian kestrel Falco tinnunculus and barn owl Tyto alba nestlings. Corticosterone pellets designed for a 7-day-release in rodents elevated circulating baseline total corticosterone during only 2-3 days compared to placebo-nestlings. Highest levels occurred 1-2 days after implantation and levels decreased strongly thereafter. CBG capacity was also increased, resulting in a smaller, but still significant, increase in baseline free corticosterone levels. The release of endogenous corticosterone as a response to handling was strong in placebo-nestlings, but absent 2 and 8 days after corticosterone pellet implantation. This indicates a potential shut-down of the hypothalamo-pituitary-adrenal axis after the 2-3 days of elevated baseline corticosterone levels. 20 days after pellet implantation, the endogenous corticosterone response to handling of nestlings implanted with corticosterone pellets attained similar levels as in placebo-nestlings. Self-degradable pellets proved to be an efficient tool to artificially elevate circulating baseline corticosterone especially in field studies, requiring only one intervention. The resulting peak-like elevation of circulating corticosterone, the concomitant elevation of CBG capacity, and the absence of an endogenous corticosterone response to an acute stressor have to be taken into account.
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Introduction
Exogenous administration of glucocorticoids is a widely used and efficient tool to investigate the effects of elevated concentrations of these hormones. Methods to artificially elevate glucocorticoids include single or repeated injections (e.g. Remage-Healey and Romero, 2002; Loiseau et al., 2008) , adding hormone to the food or drinking water (e.g. Breuner et al., 1998; Hiebert et al., 2000; Hull et al., 2007) , or implantation of a silastic tube filled with crystalline hormone (e.g. Silverin, 1986; Wingfield and Silverin, 1986; Kitaysky et al., 2001 ), a gelling material containing hormone (French et al., 2007) , a mini-infusion pump (Donker and Beuving, 1989) or an osmotic pump (Horton et al., 2007) . These various forms of administration have different advantages and disadvantages. Injections imply repeated handling with concurrent internal adrenocortical responses when hormone levels should be elevated over days. While the intake of glucocorticoids with food or water is not invasive, the amount of assimilated glucocorticoids depends on the quantity of food or water ingested and can vary between individuals. Additionally, repeated injections and hormone consumption are very difficult to apply in free-living animals. Glucocorticoidreleasing implants or osmotic pumps require only one intervention followed by the release of a given amount of glucocorticoids over a longer period of time and are often the method of choice in field studies. However, removal of these implants requires a second intervention. An alternative method is the implantation of self-degradable corticosterone-releasing pellets, which should provide a constant release by biodegradation of the matrix and do not require subsequent removal. This method has rarely been used in experiments with wild bird species until now (e.g. Pravosudov, 2003; Bourgeon and Raclot, 2006; Bonier et al., 2007) .
In most studies the effect of corticosterone administration on circulating corticosterone is not well documented, although the levels of circulating corticosterone attained and the duration of the elevation are supposed to be decisive, since the effects of corticosterone are dose dependent (e.g. Romero, 2004) and the duration of the exposure to elevated levels is crucial. The time course of circulating baseline (sampled within 3 min after capture) corticosterone after administering corticosterone in birds has been followed in only a few studies by measuring circulating total corticosterone at a few specific time points, e.g. after several days (e.g. Kitaysky et al., 2001) . The interactions further up and downstream from corticosterone during and after an exogenous corticosterone administration have been investigated predominantly in mammals (e.g. Feldman et al., 1979; Zhao et al., 1997) and only rarely in birds. Only one study investigated the effect of corticosterone administration on corticosteroid-binding-globulin (CBG) (Breuner et al., 2003b) . We know of no study examining the response to an acute stressor after the period when circulating corticosterone was elevated.
The aim of this paper is to report our experiences with selfdegradable corticosterone-releasing pellets in an extended field study with nestling Eurasian kestrels Falco tinnunculus and barn owls Tyto alba. Specifically, we investigated (a) the time course of total circulating corticosterone during 20 days after implantation; (b) whether CBG capacity and estimated free corticosterone levels were affected by corticosterone administration, and (c) whether the response of circulating corticosterone levels to an acute stressor (handling) was affected by corticosterone administration. We predicted that CBG capacity would increase with elevated corticosterone levels and that the negative feedback regulation would decrease the endogenous response to an acute stressor in cortnestlings with elevated corticosterone compared to placebo-nestlings. For aim (b) and (c) we were interested in the acute effects of the implant and in potential mid-term effects after circulating baseline corticosterone had returned to normal levels.
Material and methods

Study species and study sites
The Eurasian Kestrel is a small, diurnal raptor. Usually, the female starts incubation after laying the third of 4-6 eggs, hence, the three oldest nestlings have about the same age. The nestlings stay in the nest for 32-39 days and reach their maximal body mass around day 23. Fieldwork was performed in North-Western Switzerland (47°25'N/7°50'E), where kestrels raise their young in nest boxes mounted on agricultural buildings in open rural landscapes. Mean brood size (± SD) of the investigated broods at the day of implantation was 4.4 ± 0.96 nestlings, mean hatching date was on 7 June ± 13 days.
The barn owl is a medium-sized, nocturnal owl species producing clutches of 2-11 eggs. Incubation starts after laying the first egg and only females incubate. The laying intervals of two to three days entail a pronounced within-brood age hierarchy. The nestlings reach their maximum body mass with 40 days and fledge with about 56 days of age. Barn owls were investigated in Western Switzerland (46°49'N/06°56'E), where they breed in nest boxes attached on barns and farm buildings. Mean brood size (± SD) of the investigated broods at the day of implantation was 5.8 ± 1.54 nestlings, mean hatching date was on 3 June ± 33 days.
Experimental corticosterone treatment
The experiment was carried out in 109 kestrel nestlings of 30 broods (13 in 2004 and 17 in 2005) and 208 barn owl nestlings of 73 broods (33 in 2004, 19 in 2005, 21 in 2006) . Hatching date was determined through regular nest box controls.
Two randomly selected nestlings out of the four oldest within a brood were implanted with a self-degradable corticosteronereleasing pellet on nestling day 13 (mean age ± SD: 13.2 ± 1.4 days) in the kestrel and nestling day 25 (mean age 27 ± 5 days) in barn owl nestlings. Pellets designed for a 7-day-release in rodents were obtained from Innovative Research of America (Sarasota, FL, USA.). Because kestrels were lighter in body mass (mean ± SD: 165 ± 22 g at implantation) than barn owls (294 ± 69 g at implantation), we implanted a 10 mg corticosterone pellet (cat # C-111) in nestling kestrels and a 15 mg corticosterone pellet (cat # G-111) in nestling barn owls. The other two of the four oldest siblings were implanted with a corresponding placebo pellet, creating two treatment groups (cort-and placebo-nestlings). Before implantation, body mass (kestrels: t = 1.44, df = 107, p = 0.153; barn owls: t = 0.71, df = 206, p = 0.478), nestling age (kestrels: t = 0.56, df = 107, p = 0.577; barn owls: t = 0.28, df = 206, p = 0.783) and the proportion of the sexes (kestrels: { 2 = 0.01, df = 1, p = 0.922; barn owls:
.09, df = 1, p = 0.752) did not differ between cort-and placebo-nestlings. The pellets were placed under the skin of the flank above the knee through a small incision. The pellets are very sensitive to alcoholic solvents, even when seemingly evaporated (based on our own observations in previous trials, and personal communication by the provider). Therefore, to prevent accelerated corticosterone release, the skin was not disinfected. The incision was closed with tissue adhesive (Histoacryl Ò , Braun, Germany). If more than four siblings were present, the fifth and following were not implanted. All methods described in this study were approved by the Swiss committee for animal research (animal experiment permit no 274 from the Cantonal Veterinarian Office of Baselland for kestrels and no 1736 from the Veterinarian Office of Vaud for barn owls).
Pellet implantation and corticosterone treatment did not affect survival of nestlings. In kestrels nestlings, between nestling day 13 and fledging, 54 of 56 placebo-nestlings (96.4%) and 60 of 61 cortnestlings (98.4%) survived, while 242 of 260 nestlings not treated with a pellet survived (93.1%; nestlings of other broods at our study site during the study years which were only measured and blood sampled). In barn owls, 40 of 43 cort-nestlings (93.0%) and 42 of 43 placebo-nestlings (97.7%) survived until fledging, while 159 of 179 non-treated nestlings (88.8%) survived until fledging. All differences in survival between cort-implanted, placebo-implanted and non-implanted birds were not significant (kestrel: Pearson { 2 = 3.12, df = 2, p = 0.210; barn owl: Pearson { 2 = 3.57, df = 2, p = 0.168).
Blood sampling
We took baseline blood samples in kestrel nestlings 3 days before implantation, on the day of implantation (day 0) and 3 and 8 days after implantation. In a subgroup of kestrel nestlings we took an additional baseline sample 1 or 2 days after implantation. All baseline samples were taken within 3 min after taking nestlings out of the nest box in batches of two. There was no effect of batch number or the time between first arrival and bleeding on baseline corticosterone (F = 0.57, df = 2, p = 0.567). In barn owls we collected a blood sample within 3 min after having opened the nest box on the day of implantation and 6 and 20 days after implantation (blood samples taken after 3 min were not used for this study); a subgroup was also sampled 2 or 3 days after implantation. In addition, we had baseline samples of 5 cort-nestlings of 4 broods 1 day after implantation which we used to demonstrate whether corticosterone levels were not pharmacologically high, but we did not include them in the statistical tests, because the corresponding placebo samples were missing. After taking the first blood sample, the nestlings were measured, weighed and then held in a cloth bag. The adrenocortical response to handling was assessed by taking a second blood sample about 17 min (mean ± SD: 16.9 ± 1.4 min, range: 15-22) after taking the nestlings out of the nest box in kestrels and 19 min (19.13. ± 2.92 min, range: 15-25) in barn owls. Handling-induced corticosterone levels did not vary within these time ranges (Placebo-nestlings: p > 0.242). Blood was sampled by puncturing the alar vein and collected in heparinized capillary tubes. Within 30 min, the blood was centrifuged in Eppendorf tubes and the plasma immediately stored in liquid nitrogen in the field and at À20°C once in the laboratory.
Corticosterone assay
Plasma corticosterone concentration was determined using an enzyme immuno assay (Munro and Stabenfeldt, 1984; Munro and Lasley, 1988) . Five microliter of plasma was added to 195 ll water, and from this solution we extracted corticosterone with 4 ml dichloromethane, which was re-dissolved in phosphate buffer and measured in triplicates in the enzyme immunoassay. The dilution of the corticosterone antibody (Chemicon; cross-reactivity: 11-dehydrocorticosterone 0.35%, Progesterone 0.004%, 18-OH-DOC 0.01%, Cortisol 0.12%, 18-OH-B 0.02% and Aldosterone 0.06%) was 1:8'000. HRP (1:400'000) linked to corticosterone served as enzyme label and ABTS as substrate. The concentration of corticosterone in plasma samples was calculated by using a standard curve run in duplicate on each plate. Plasma pools from chickens with two different corticosterone concentrations were included as internal controls on each plate. In 38 cases the concentration was below the detection threshold, and in this case the determination was repeated with 10 ll plasma. If the concentration was still below the detection threshold (27 samples), the value of the lowest detectable concentration (1 ng ml À1 ) was assigned. Intra-assay variation ranged from 4.5% to 13.4% and inter-assay variation from 9.6% to 23.0%, depending on the concentration of the internal control and the year of determination.
Corticosteroid-binding-globulin
The affinity and capacity of corticosteroid-binding-globulin (CBG) was measured with a radioligand-binding assay with tritiated corticosterone following Breuner et al. (2003a) . For point sample analysis, plasma (10-15 ll in the kestrel, 5 ll in the barn owl) was stripped of endogenous steroids with two parts of dextrancoated charcoal (0.1% dextran, 1% Norit A charcoal in 50 mM Tris) for 30 min at room temperature. Outside this stripping procedure, the plasma was maintained below 4°C. The final assay dilution of kestrel plasma samples was 1:99, those of the barn owl samples 1:450. The binding assay was carried out in 50 nM Tris buffer at 4°C and terminated after 2 h. 1 h before filtering, glass fiber filters (Whatman) were soaked in 25 nM Tris with 0.3% polyethyleneimine. After filtration, filters were rapidly rinsed with three rinses of 3 ml ice-cold 25 nM Tris. Point sample analysis was performed with individual plasma samples, for the saturation analyzes pooled samples were run. For the saturation analyzes, 0. Fig. 1A and B) indicated that this ligand concentration occupies $80% of total binding sites. For analysis, the samples were corrected to 100% capacity within each assay. The intra-assay variation was 5.7% and 7.1%, the inter-assay variation 7.58% and 17.1% (kestrel and barn owl samples determined separately). The equation of Barsano and Baumann (1989) was used to estimate free corticosterone titers from total corticosterone concentrations and CBG binding parameters
where H free is free Hormone, H total is total Hormone, B max is total binding capacity of CBG, and K a = 1/dissociation constant (K d ) (all values in nM). Corticosterone was analyzed in all baseline and handling induced blood samples, CBG capacity was measured in all baseline kestrel and barn owl samples and a subsample of the handling induced kestrel samples (a subsample of day 10, all samples of day 21).
Statistical analyses
To analyze the overall effect of corticosterone treatment on circulating corticosterone we performed mixed models (REML, Genstat 10) separately with total corticosterone, CBG capacity and free corticosterone as dependent variables. We included treatment (corticosterone versus placebo) and time after implantation (number of days after implantation) and their interaction as fixed factors and nestling identity nested in broods as random factors to correct for the dependence of siblings within a brood. The effect of corticosterone treatment on the response to handling was analyzed separately for total and free corticosterone and CBG capacity by running a repeated measures analysis including baseline and stress-induced levels of those days with two blood samples per individual. The model included time after implantation, treatment, blood sample (baseline versus handling-induced) and their interactions as fixed factors, and nestling identity nested in brood as random factors. To compare corticosterone levels of baseline and handling-induced blood samples and CBG capacity between treatment groups at the different sampling days, we performed post-hoc tests for each day separately. Treatment was included as fixed and brood as random factor in these mixed models and significance levels were adjusted according to Bonferroni (Sokal and Rohlf, 2000) . Kestrel and barn owl data were analyzed in separate models.
Results
3.1. Effect of corticosterone pellets on baseline total and free corticosterone levels and CBG capacity Implanting a corticosterone pellet had a highly significant effect on the plasma concentration of total corticosterone in both species (Table 1 and 2). Before implantation, there was no difference in total corticosterone level between cort-and placebo-nestlings in both species ( Fig. 2A and B) . Total corticosterone in kestrel cortnestlings was significantly elevated over placebo-nestlings 1 day after implantation (post-hoc test: F = 39.14, df = 1, 10.4, p < 0.001, Fig. 2A, Fig. 3A , range: 29.78-63.80 ng/ml), and tended towards significance 2 days after implantation (F = 7.92, df = 1, 4.6, p = 0.037, not significant at the Bonferroni-corrected p-level of 0.013); corticosterone levels were indistinguishable from those of placebo-nestlings 3 and 8 days after implantation. In barn owl nestlings, total corticosterone in cort-nestlings was significantly increased 2 days after implantation (F = 66.78, df = 1, 80.0, p < 0.001, Fig. 2B, Fig. 3B , range 2 days after implantation: 8.11-118.03 ng/ml) and returned to the level of placebo-nestlings 3, 6 and 20 days after implantation (p > 0.161). The five values of cort-nestlings 1 day after implantation (range 10.7-48.1 ng/ml) indicated that levels were not higher than 2 days after implantation.
CBG capacity in kestrel nestlings did not significantly vary with time or treatment (Table 1) , and CBG capacity was not significantly elevated on day 1 and 2 after cort-implantation ( Fig. 2C ; 1 day: F = 0.80, df = 1, 13.0, p = 0.386, day 2: F = 1.58, df = 1, 2.3, p = 0.335). In barn owl nestlings, there was an overall effect of treatment and time and their interaction on CBG capacity (Table  2 , Fig. 2D ). CBG capacity of barn owl cort-nestlings was significantly elevated 2 days after implantation (F = 37.13, df = 1, 69.7, p < 0.001) and indistinguishable from placebo-nestlings 3, 6 and 20 days after implantation.
Estimated free corticosterone levels varied with time and treatment group depending on time after implantation in both species (Table 1 and 2). There was no difference between the treatment groups before implantation in both species (Fig. 2E and F) . In kestrels, although the interaction term time after implantation x treatment was highly significant (Table 1) , the Bonferroni-corrected post-hoc tests indicated just no significant difference between cort-nestlings and placebo-nestlings one day after implantation (F = 5.33, df = 1, 13.0, p = 0.038, Fig. 2E , not significant at the Bonferroni-corrected p-level of 0.013), and no difference between the treatment groups 2, 3 and 8 days after implantation (p = 0.236, 0.847 and 0.072, respectively). In barn owl nestlings, free corticosterone of cort-nestlings was significantly elevated two days after implantation, (F = 26.06, df = 77.8, p < 0.001), while 3, 6 and 20 days after implantation there was no difference between the treatment groups (p = 0.657, 0.153 and 0.733, respectively, Fig. 2F ).
Effect of corticosterone pellets on handling-induced total and free corticosterone levels and CBG capacity
In both species, total and free corticosterone levels depended on time after implantation, treatment group and blood sample (baseline versus handling-induced) (interaction time Â treatment group Â blood sample p < 0.001, Table 3 ).
Placebo-nestlings of both species showed a marked increase of total plasma corticosterone levels as a response to handling. In cort-nestlings 2 days after implantation (barn owl, Fig. 4B ), when baseline total corticosterone levels were elevated, plasma corticosterone levels increased only little as a response to handling and reached similar levels as in placebo-nestlings (treatment: F = 2.33, df = 1, 120.8, p = 0.130). In cort-nestlings 8 days after implantation (kestrel, Fig. 4A ), when baseline levels were low again, the adrenocortical response to handling was virtually absent (interaction time after implantation Â treatment group Â blood sample p < 0.001, Table 3 , Fig. 4A ). In barn owl nestlings 20 days after implantation, when baseline levels were similar in both treatment groups, cort-nestlings reached similar handling-induced levels as the placebo-nestlings (F = 3.99, df = 1, 37.6, p = 0.053, Fig. 4B ).
Discussion
Effect of corticosterone pellets on total baseline corticosterone levels
The self-degradable corticosterone pellets clearly increased circulating total baseline corticosterone levels in kestrel and barn owl nestlings 1-3 days after implantation compared with placebo-nestlings. With the 10 mg and 15 mg 7-day-release pellets used in this study, the increase in corticosterone levels was within the range reached by handling before the treatment (kestrel nestlings 8-50 ng/ml after 17 min; barn owl nestlings 10-110 ng/ml after 19 min) and therefore, within the physiological range. Although the increase in corticosterone levels induced by the pellets varied between individuals, they were clearly higher than in placebo-nes- Table 1 Effect of corticosterone pellets on plasma levels of total baseline corticosterone, CBG capacity and estimated free corticosterone in kestrel nestlings. Treatment group refers to 56 nestlings implanted with a corticosterone pellet and 53 nestlings implanted with a placebo pellet. Time after implantation refers to blood samples taken 3 and 0 days before and 3 and 8 days after implantation from all nestlings and 1 or 2 days after implantation from 25 nestlings (470 measurements in total). The results from a mixed model analysis are given with nestling identity nested in broods as random factors. tlings ( Fig. 3A and B) . However, baseline corticosterone levels were not elevated to a constant level, but peaked 1-2 days after implantation, dropped to a lower level 2 days after implantation (in the kestrel) and had almost reached placebo-levels 3 days after implantation. Thus, with these pellets, corticosterone levels were elevated for a shorter period than the 7 days indicated by the provider and similar findings were obtained in house sparrows (C.W.B.
unpublished data). There are two possible explanations. First, the corticosterone contained in the pellet may have been released very fast, resulting in peak-like levels higher than intended. It is possible, that the pellet matrix is metabolized faster and corticosterone released in a shorter time period in birds than in mammals, for which the pellet was designed originally. A second explanation is that through the internal negative feedback the release of endoge- Table 2 Effect of corticosterone pellets on plasma levels of total baseline corticosterone, CBG capacity and estimated free corticosterone in barn owl nestlings. Treatment group refers to 96 nestlings implanted with a corticosterone pellet and 91 nestlings implanted with a placebo pellet. Time after implantation refers to blood samples taken at day 0 (n = 144), 2 (n = 92), 3 (n = 28), 6 (n = 47) or 20 days (n = 78) after implantation (389 measurements in total). The results from a mixed model analysis are given with nestling identity nested in broods as random factors. . Exceptions in sample size are day 1 and 2 after implantation in the kestrel with only 4-9 samples per treatment group, day 1 after implantation in the barn owl with only 5 cort-nestlings and day 3 in barn owls with only 14 samples per treatment group. The pellet was implanted on day 0, which corresponded to an age of 13 days in kestrels and 27 days in barn owls.
nous corticosterone was strongly reduced until the pellet was metabolized. The finding that the glucocorticoid response to handling was strongly reduced up to 8 days after implantation may suggest that the negative feedback mechanism was indeed in operation (see below). Future studies, using pellets with labeled corticosterone, are needed to determine the relative amounts of endogenous and exogenous corticosterone in the blood and, thus, the importance of the internal negative feedback mechanism to regulate plasma levels of corticosterone after external administration. In a study implanting silastic tubes filled with corticosterone in starlings Sturnus vulgaris and black-legged kittiwakes Rissa tridactyla, plasma corticosterone levels also had decreased to near placebo-levels 3 or 5 days after implantation (Romero et al., 2005; Angelier et al., 2007) , also indicating a potential negative feedback regulation reducing the adrenocortical corticosterone release after some days. Studies using other techniques to administer corticosterone unfortunately do not present the time course of circulating corticosterone after administration. Usually, the resulting circulating corticosterone levels were measured only once at varying time points after the beginning of administration, which prevents the comparison of the time course of corticosterone levels between different methods.
The variation between individuals in baseline corticosterone levels 1-2 days after implantation was quite large (Fig. 3 ). Similar data from published studies using other ways of administering corticosterone are not known to us. It is well established that baseline and handling-induced corticosterone levels (not induced by implants) vary considerably between individuals (e.g. Cockrem and Silverin 2002) , hence, there is considerable individual variation in the functioning of the HPA axis that may also hold when 
Table 3
Effect of corticosterone pellets on total baseline and handling induced corticosterone levels in kestrel and barn owl nestlings. Treatment group refers to nestlings implanted with a corticosterone or a placebo pellet. Time after implantation in the kestrel refers to blood samples taken 3 days before implantation (n = 106) and 8 days after implantation (n = 103) and, in the barn owl, to blood samples taken at day 0 (n = 75), and 2 (n = 158) or 20 days (n = 51) after implantation. Blood sample refers to the baseline sample (taken within 3 min) and the handling-induced sample (taken on average 17 (kestrel) or 19 min (barn owl) after capture). The results from a mixed model analysis are given with nestling identity nested in broods as random factors. administering corticosterone. We found that individual variation in corticosterone levels after implantation in barn owls depends on environmental conditions (Almasi et al., unpublished data) and are correlated with a genetically determined color trait (Almasi et al., unpublished data) . Hence, the ability to buffer administered corticosterone seems to be an interesting individual trait in itself.
4.2. Effect of corticosterone pellets on CBG capacity and free baseline corticosterone levels
Concurrent to the increased corticosterone levels, the pellets also increased CBG capacity in barn owl nestlings and tended to increase CBG capacity (small sample size) in kestrel nestlings. This corresponds to increased plasma CBG in house sparrows Passer domesticus and serum CBG in mouse pups after glucocorticoid administration (Zhao et al., 1997; Breuner et al., 2003b) , but is in contrast to a decrease in CBG production and secretion in rats after glucocorticoid administration (Feldman et al., 1979) . It is possible, that the increase in CBG capacity serves to protect partly from the deleterious interferences of high free corticosterone levels with postnatal morphological and cognitive development (Kitaysky et al., 2003, Müller et al., unpublished data) . However, the course of free baseline corticosterone correlated strongly with total baseline corticosterone levels, and the peak in total corticosterone concentration after pellet implantation was buffered only to a small degree by the simultaneously elevated CBG capacity. We did not find any impact of the corticosterone pellets on CBG capacity after the peak of circulating baseline corticosterone.
Effect of corticosterone pellets on the adrenocortical response to handling
There was only a small adrenocortical response to handling two days after corticosterone pellet implantation in barn owl nestlings and virtually no adrenocortical response to handling 8 days after corticosterone pellet implantation in kestrel nestlings. This can be explained by the negative feedback mechanism controlling circulating corticosterone levels (e.g. Keller-Wood and Dallman, 1984; McEwen et al., 1986) . The negative feedback can occur as a rate-sensitive fast feedback and a level-sensitive delayed feedback (Dallman and Yates, 1969) . The delayed feedback begins approximately 30 min following glucocorticoid elevation and extends for days. The duration of the subsequent inhibition of the axis depends on the absolute concentration of the steroids, thus may extend beyond the period of hormone administration (e.g. Abe and Critchlow, 1980; Sapolsky et al., 1986 ).
An attenuated adrenocortical response to an acute stressor, as we observed 2 days after implantation in barn owls, occurs when the animal is already under chronic stress as provoked here by corticosterone administration. As a result of a rate-sensitive fast feedback the hypothamalo-pituitary-adrenal axis shuts down and is not capable of mounting a response to an acute stress (Romero, 2004) . One example in free-living birds is the absence of any further corticosterone elevation to capture and handling in a seabird, when a severe storm had already substantially increased circulating corticosterone (Smith et al., 1994) . The absence of an adrenocortical response to handling in kestrel nestlings eight days after corticosterone pellet implantation (when baseline total corticosterone levels were not elevated anymore) may be explained by an extension of a level-sensitive delayed feedback. Alternatively, it may be explained by the continuous release of corticosterone from the pellet provoking the shut-down of the hypothamalo-pituitaryadrenal axis, as mentioned above.
Twenty days after corticosterone pellet implantation, the HPA axis seemed to have recovered from the corticosterone manipulation. As a response to handling barn owl cort-nestlings showed a similar increase in circulating total corticosterone levels as placebo-nestlings.
Conclusions
Self-degradable pellets are an efficient tool to artificially elevate corticosterone levels with one intervention. The dose and duration-dependent effects of corticosterone require the monitoring of the resulting circulating corticosterone levels. It is to be expected, that the release from pellets, and possibly from other implants, is not constant over time or that a delayed feedback sets in after a few days which both result in different plasma levels, and thus possibly different effects, of corticosterone at different stages during the experiment. The plasma levels resulting from corticosterone administration can be monitored in a subgroup within the experiment, in an additional group of implanted control animals or in a preliminary study. However, since the HPA axis can vary with season, life history stage, environmental conditions, age and sex (e.g. Wingfield et al., 1994; Kitaysky et al., 1999; Romero, 2002; O'Reilly and Wingfield, 2003; Love and Williams, 2008) , any additional group should closely match the experimental groups and live under similar conditions and at the same time or season. Indeed, there is individual variation in corticosterone levels as a response to pellet implantation depending on baseline levels (own unpublished data) and nutritional conditions (Almasi et al., unpublished data) .
When using self-degradable corticosterone pellets, no alcohol or similar solvent should be used during implantation, because even if seemingly evaporated, alcohol can strongly increase the release of corticosterone from the pellet. We also recommend to carefully determine the dosage of the pellet in test birds to avoid pharmacological levels during the first days after implantation.
The interactions of exogenous corticosterone with the negative feedback mechanism and the response to an acute stressor have to be taken into account in future studies. An increase in CBG capacity provoked by corticosterone administration results in an attenuated increase in circulating free baseline corticosterone levels compared with total levels, which may modify the effects of corticosterone on the animal.
